BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld
BioWorld
April 25, 2005
View Archived Issues
Lifted By Higher Product Sales, Amgen Beats Consensus EPS
Beating Wall Street estimates, Amgen Inc. performed well in the first quarter, reporting strong revenue for most of its products, despite Medicare reimbursement changes. (BioWorld Today)
Read More
Solexa Signs Deal To Raise $32.5M, Advance Platform
Read More
Novel Approach To Synthesis Causing Tetracycline Variety
Read More
Recent Stem Cell Bill Forbids Human Reproductive Cloning
Read More
Hamilton Pharmaceuticals' First Financing: $11M For CNS Drugs
Read More
Other News To Note
Read More